Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Why Novo Nordisk (NVO) is a Top Value Stock for the Long-Term
10:41am, Monday, 07'th Jul 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Italy set to speed through $2.3 billion Novo Nordisk investment
08:50am, Monday, 07'th Jul 2025
Italian authorities on Monday appointed a special commissioner to help Danish drugmaker Novo Nordisk speedily deliver its promised 2 billion-euro ($2.34 billion) investment in a factory south of Rome.
2 Stocks to Buy on the Dip and Hold for 10 Years
09:45am, Sunday, 06'th Jul 2025
One of Warren Buffett's famous pieces of investing advice is to be greedy when others are fearful. One way to apply this wisdom is to look for companies that have lagged the market recently but still
Novo Nordisk's Sell-Off Has Gone Too Far
09:33am, Sunday, 06'th Jul 2025
Novo Nordisk's recent sell-off is overdone; current fears around pricing and CagriSema are temporary, creating a compelling buying opportunity. The company's fundamentals remain strong, with robust sa
2 International Dividend Stocks For Retirees
08:54am, Saturday, 05'th Jul 2025
Retirees looking for dividend growth stocks at a reasonable price have ample reasons to look outside of America, especially with the S&P 500 skyrocketing to new all-time highs and, with that, a somewh
Are You Looking for a High-Growth Dividend Stock?
12:46pm, Friday, 04'th Jul 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novo Nordisk (NVO) have what it takes?
Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?
10:56am, Friday, 04'th Jul 2025
NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Wednesday, 02'nd Jul 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note
06:45pm, Tuesday, 01'st Jul 2025
Novo Nordisk (NVO) reached $69.82 at the closing of the latest trading day, reflecting a +1.16% change compared to its last close.
Novo Nordisk: The Pullback Is Noise - The Buy Case Is Stronger Than Ever
12:30pm, Tuesday, 01'st Jul 2025
Novo Nordisk's fundamentals remain robust despite recent share price weakness, with strong sales and profit growth as well as a well-established pipeline. Concerns over CEO transition and compounding
Mizuho's Jared Holz: Novo Nordisk is trying to come up with strategies to regain market share
11:26am, Tuesday, 01'st Jul 2025
Jared Holz, Mizuho Securities health care strategist, joins CNBC's 'Squawk on the Street' to discuss weight loss drug makers, how CVS is boosting access to Wegovy, and more.
Insight: How Novo Nordisk misread the US market for its weight loss sensation
06:07am, Tuesday, 01'st Jul 2025
Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the Danish drugmaker in a more vulnerable
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know
10:00am, Monday, 30'th Jun 2025
Novo Nordisk (NVO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
7 Killer European Stocks To Buy In July
10:52am, Sunday, 29'th Jun 2025
As you look at the stock markets around the world, it's always a balance of trying to decide when is the right time to buy.
3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
08:36am, Sunday, 29'th Jun 2025
With the notable exceptions of Novo Nordisk A/S NYSE: NVO and Eli Lilly & Co. NYSE: LLY, biotechnology stocks had a rough time attracting investment capital in 2024. Small- and mid-cap biotech stocks
